Ocular Therapeutix (OCUL) Surges 382% in 3 Years
Ocular Therapeutix Inc (NASDAQ:OCUL) is a biotechnology company founded with the vision of transforming the way ophthalmic disorders…
Zevra Therapeutics (ZVRA) Poised for Growth After Adding High-Profile Biopharma CEO to Board
Zevra Therapeutics Inc. (NASDAQ:ZVRA) is a commercial-stage biopharmaceutical company that has evolved into a recognized leader in the…
Syndax Pharmaceuticals Inc (SNDX) Skyrockets 76.88% in 6 Months
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) is a clinical stage biopharmaceutical company that has evolved into one of the most…
Bright Minds Biosciences (DRUG) Appears 44% Undervalued — DCF Shows Fair Value at CA$182
Bright Minds Biosciences Inc. (NASDAQ:DRUG) is a clinical stage biopharmaceutical company that has steadily built its identity as…
Quantum BioPharma (QNTM) Takes Center Stage as CTV’s W5 Exposes Alleged $700M Stock Manipulation Scheme
Quantum BioPharma Ltd. (NASDAQ:QNTM), formerly known as FSD Pharma before its strategic transformation, has evolved into a rapidly…
Amarin (AMRN) Posts 17% Revenue Surge: Is This the Start of a Massive Turnaround?
Amarin Corporation plc (NASDAQ:AMRN) has evolved into one of the most closely watched companies in the global cardiovascular…
Cadrenal Therapeutics (CVKD) Surges in Attention After Q3 2025 Update Reveals Big Pipeline Moves
Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) is an emerging biopharmaceutical company focused on developing next-generation anticoagulant therapies designed to…
Ardelyx (ARDX) Tops Q3 With $110.33M Revenue
Ardelyx Inc. (NASDAQ:ARDX) is a commercial-stage biopharmaceutical company focused on developing and delivering first-in-class medicines for patients suffering…
Kymera Therapeutics (KYMR) Jumps 10.2% in a Month—Is Wall Street Pricing in a Major 2026 Breakout?
Kymera Therapeutics Inc. (NASDAQ:KYMR), a publicly traded biotechnology company, was founded to pioneer the rapidly expanding field of…
Biodexa Pharmaceuticals (BDRX) Launches Phase 3 Trial for eRapa — Can This $2.81M Biotech Transform FAP Treatment?
Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for diseases with significant…
Galectin Therapeutics (GALT) Surges 10.5% After Insider Sells 120,000 Shares
Galectin Therapeutics Inc. (NASDAQ:GALT) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for fibrotic disease, cancer,…
Analysts Boost Target to $24 as Ocular Therapeutix (OCUL) Nears Major Catalyst
Ocular Therapeutix, Inc. is a biotechnology company dedicated to transforming the treatment landscape for serious ocular diseases through…
Enveric Biosciences (ENVB) Reports Breakthrough PTSD Results as EB-003 Moves Toward IND in 2026
Enveric Biosciences Inc (NASDAQ:ENVB) is a biotechnology company built on a scientific foundation of developing next-generation neuroplastogenic therapeutics…
Sensei Biotherapeutics (SNSE) Cuts Workforce by 65% as It Prepares for a Potential Sale—Is a Major Buyout Coming?
Sensei Biotherapeutics Inc (NASDAQ:SNSE) is a clinical stage biotechnology company built on a foundation of innovative cancer research…
Viking Therapeutics (VKTX) Surges After 78% of Patients Achieve Normal Glycemic Control in Obesity Trial
Viking Therapeutics Inc. (NASDAQ:VKTX) is a clinical-stage biotechnology company dedicated to developing innovative therapies for metabolic disorders, obesity,…
Biodexa Pharmaceuticals (BDRX) Launches Phase 3 Trial for eRapa — Can This $2.8M Biotech Deliver a Breakthrough?
Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) is a clinical-stage biopharmaceutical company operating within the biotechnology industry and focused on discovering,…
West Pharmaceutical Services (WST) Could Outperform as Analysts Project $350.77 Price Target
West Pharmaceutical Services Inc. (NYSE:WST) is one of the most established and influential companies in the global pharmaceutical…
Don’t Let the 70.7% YTD Jump Fool You—Axsome Therapeutics (AXSM) Still Faces Massive Downside Risk
Axsome Therapeutics (NASDAQ:AXSM) is a clinical-stage biopharmaceutical company that has grown into one of the most closely watched…